Mutant prevention concentrations for four fluoroquinoloneswith staphylococcus aureus and escherichia coli
- At: 2007 FIP Congress in Beijing (China)
- Type: Poster
- By: WANG, Rui (Chinese PLA General Hospital, Beijing, China)
- Co-author(s): Liang, Bei-Bei (Chinese PLA General Hospital, BEIJING, China)
Zheng, Zhuang-Jie (Chinese PLA General Hospital, BEIJING, China)
Qian, Jiao (Chinese PLA General Hospital, BEIJING, China)
OBJECTIVE: The mutant prevention concentration (MPC) has recently been defined to characterize the capacity for severely restricting the selection of resistant mutants during antibiotic treatment. MPC and MIC against S. aureus and E. coli of ciprofloxacin, pazaufloxacin, gatifloxacin, moxifloxacin were determined and the potent of the four FQs to.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.